Codes / ICD10CM / M84.539G

M84.539G Pathological fracture in neoplastic disease, unspecified ulna and radius, subsequent encounter for fracture with delayed healing

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Pathological Fracture in Neoplastic Disease, Unspecified Ulna and Radius, Subsequent Encounter for Fracture with Delayed Healing (ICD-10-CM: M84.539G)

Summary

This condition describes a pathological fracture of the ulna and radius due to underlying neoplastic disease, occurring during a subsequent encounter when healing is delayed. The fracture results from weakened bone structure caused by cancer, rather than direct trauma. It represents a complication of malignancy affecting the forearm bones, where healing progress is slower than expected, requiring ongoing management.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the ulna and radius, compromising their structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode forearm bone, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction, treatment-related effects (e.g., radiation therapy), or systemic therapies that weaken bone may also contribute to delayed healing.

Risk Factors

  • History of cancer with bone metastasis to the forearm.
  • Advanced-stage malignancies with skeletal involvement.
  • Tumors that preferentially affect bone (e.g., multiple myeloma).
  • Prior radiation therapy to forearm sites.
  • Systemic therapies that impair bone healing (e.g., certain chemotherapies).

Symptoms

  • Persistent pain at the fracture site despite treatment.
  • Limited mobility or function of the forearm.
  • Visible deformity or swelling.
  • Delayed union or nonunion of the fracture on imaging.
  • Associated symptoms of the underlying neoplastic disease.

Diagnosis

Diagnosis involves clinical evaluation of the fracture site, imaging (e.g., X-rays, CT, or MRI) to assess bone integrity and healing progress, and correlation with the patient’s cancer history. Laboratory tests may include tumor markers or bone turnover markers. The "subsequent encounter" and "delayed healing" modifiers indicate ongoing management after initial treatment, with documentation of healing status.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying neoplastic disease. Options may include immobilization, surgical fixation, or bone-stimulating therapies. Oncologic management (e.g., chemotherapy, radiation) is adjusted to support healing. Multidisciplinary care involving orthopedics and oncology is often required.

Prognosis and Follow-Up

Prognosis depends on the extent of bone damage, the type and stage of the underlying cancer, and response to treatment. Delayed healing may prolong recovery, requiring extended follow-up. Regular imaging and clinical assessments monitor healing progress and adjust management as needed.

Complications

  • Nonunion or malunion of the fracture.
  • Persistent pain or functional impairment.
  • Progression of the underlying neoplastic disease.
  • Infection at the fracture site.
  • Need for additional interventions (e.g., surgery).

Lifestyle & Prevention

  • Avoid high-impact activities that stress the forearm.
  • Follow oncologic treatment plans to control the underlying disease.
  • Maintain bone health through nutrition (e.g., calcium, vitamin D) if appropriate.
  • Use assistive devices to reduce weight-bearing on the affected limb.

When to Seek Professional Help

Seek care if pain worsens, swelling increases, or mobility declines significantly. Prompt evaluation is needed if signs of infection (e.g., redness, fever) or new fractures occur. Contact a healthcare provider if healing progress stalls or symptoms recur.

Tips for Medical Coders

Document the "subsequent encounter" and "delayed healing" modifiers clearly, with evidence of ongoing fracture management and healing status. Include details of the underlying neoplastic disease and any contributing factors (e.g., prior treatments) to support code assignment. Ensure clinical documentation aligns with the specific encounter type and healing timeline.

Book a walkthrough

M84.539G policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.